English

SOLAZYME INC

EDGAR

SZYM Quarterly report (10-Q) · filed 2017-05-05

29 filing records in this dataset, filed from 2011-03-11 to 2017-05-05. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

4.52 million USD

2017 Q1 · USD

Exact inputs and evidence

Revenue: 4519000 USD Source

Operating margin

-246.58%

2017 Q1 · %

Exact inputs and evidence

Operating Income: -11143000 USD Source
Revenue: 4519000 USD Source

Operating cash flow

-13.3 million USD

2017 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -13347000 USD Source

Free cash flow

-13.4 million USD

2017 Q1 · USD

Exact inputs and evidence

Operating Cash Flow: -13347000 USD Source
Capital Expenditure: 27000 USD Source

Cash and cash equivalents: 44.8 million USD 2017-03-31 Source
Exact value

44813000 USD
Long-term debt including current maturities: 173 million USD 2017-03-31 Source
Exact value

172991000 USD
Shares outstanding: 108 million shares 2017-03-31 Source
Exact value

108305000 shares

Reported share-count change

31.59% · 26 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

82307159 shares · 2016-03-31· Source
108305000 shares · 2017-03-31· Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-05-05.

Financial data available through: 2016-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2016-12-31
Operating income: 7 of 11 periods available· newest 2016-12-31
Net income: 7 of 11 periods available· newest 2016-12-31
Operating cash flow: 7 of 11 periods available· newest 2016-12-31
Capital expenditure: 7 of 11 periods available· newest 2016-12-31
Total assets: 6 of 11 periods available· newest 2016-12-31
Total liabilities: 6 of 11 periods available· newest 2016-12-31
Current assets: 6 of 11 periods available· newest 2016-12-31
Current liabilities: 6 of 11 periods available· newest 2016-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2016-12-31
Long-term debt including current maturities: 6 of 11 periods available· newest 2016-12-31
Shares outstanding: 6 of 11 periods available· newest 2016-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-19.1%

Prior period

USD 22.85 million

2015-01-01 – 2015-12-31
Current period

USD 18.48 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

18482000 − 22853000 = -4371000 USD

22853000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
18482000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Year-over-year change in Revenue: -4371000 USD Concept: fundies:Revenue Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 18482000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#458143 Filing: 000131123017000008 Input fundies:Revenue: 22853000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#456960 Filing: 000131123017000008
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 39.84 million

Prior period

−USD 141.4 million

2015-01-01 – 2015-12-31
Current period

−USD 101.56 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-101556000 − -141400000 = 39844000 USD

-141400000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-101556000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Year-over-year change in Net income: 39844000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -101556000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#400690 Filing: 000131123017000008 Input fundies:NetIncome: -141400000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#399695 Filing: 000131123017000008
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 20.62 million

Prior period

−USD 85.12 million

2015-01-01 – 2015-12-31
Current period

−USD 64.5 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

-64500000 − -85115000 = 20615000 USD

-85115000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
-64500000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Year-over-year change in Operating cash flow: 20615000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -64500000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#397421 Filing: 000131123017000008 Input fundies:OperatingCashFlow: -85115000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#396997 Filing: 000131123017000008
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+55%

Prior period

USD 1.24 million

2015-01-01 – 2015-12-31
Current period

USD 1.92 million

2016-01-01 – 2016-12-31

Exact inputs and evidence

1923000 − 1241000 = 682000 USD

1241000 USD · 2015-01-01 – 2015-12-31
Inspect prior input Prior source
1923000 USD · 2016-01-01 – 2016-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Year-over-year change in Capital expenditure: 682000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1923000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423736 Filing: 000131123017000008 Input fundies:CapitalExpenditure: 1241000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423526 Filing: 000131123017000008
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2016-01-01 – 2016-12-31

Revenue USD 18.48 million 100% of revenue
Operating costs Derived USD 81.53 million 441% of revenue
Operating income −USD 63.04 million −341% of revenue
Tax, interest and other Derived USD 38.51 million 208% of revenue
Net income −USD 101.56 million −549% of revenue

Cash

Operating cash flow −USD 64.5 million −349% of revenue
Capital expenditure USD 1.92 million 10% of revenue
Free cash flow Derived −USD 66.42 million −359% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2010 Operating loss: operating costs were 136% of revenue.
2011 Operating loss: operating costs were 230% of revenue.
2012 Operating loss: operating costs were 293% of revenue.
2013 Operating loss: operating costs were 342% of revenue.
2014 Operating loss: operating costs were 475% of revenue.
2015 Operating loss: operating costs were 550% of revenue.
2016 Operating loss: operating costs were 441% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2010 2010-01-01 – 2010-12-31	37970000	51649000 Derived	-13679000	2601000 Derived	-16280000	-10814000 Derived	Source 2010-01-01 – 2010-12-31: 37970000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: -13679000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: -16280000 USD Inspect Net Income Open source 2010-01-01 – 2010-12-31: -8309000 USD Inspect Operating Cash Flow Open source 2010-01-01 – 2010-12-31: 2505000 USD Inspect Capital Expenditure Open source
2011 2011-01-01 – 2011-12-31	38966000	89459000 Derived	-50493000	3408000 Derived	-53901000	-50407000 Derived	Source 2011-01-01 – 2011-12-31: 38966000 USD Inspect Revenue Open source 2011-01-01 – 2011-12-31: -50493000 USD Inspect Operating Income Open source 2011-01-01 – 2011-12-31: -53901000 USD Inspect Net Income Open source 2011-01-01 – 2011-12-31: -34905000 USD Inspect Operating Cash Flow Open source 2011-01-01 – 2011-12-31: 15502000 USD Inspect Capital Expenditure Open source
2012 2012-01-01 – 2012-12-31	44108000	129211000 Derived	-85103000	-1971000 Derived	-83132000	-80125000 Derived	Source 2012-01-01 – 2012-12-31: 44108000 USD Inspect Revenue Open source 2012-01-01 – 2012-12-31: -85103000 USD Inspect Operating Income Open source 2012-01-01 – 2012-12-31: -83132000 USD Inspect Net Income Open source 2012-01-01 – 2012-12-31: -67571000 USD Inspect Operating Cash Flow Open source 2012-01-01 – 2012-12-31: 12554000 USD Inspect Capital Expenditure Open source
2013 2013-01-01 – 2013-12-31	39750000	135890000 Derived	-96140000	20249000 Derived	-116389000	-85007000 Derived	Source 2013-01-01 – 2013-12-31: 39750000 USD Inspect Revenue Open source 2013-01-01 – 2013-12-31: -96140000 USD Inspect Operating Income Open source 2013-01-01 – 2013-12-31: -116389000 USD Inspect Net Income Open source 2013-01-01 – 2013-12-31: -74790000 USD Inspect Operating Cash Flow Open source 2013-01-01 – 2013-12-31: 10217000 USD Inspect Capital Expenditure Open source
2014 2014-01-01 – 2014-12-31	35962000	170681000 Derived	-134719000	27422000 Derived	-162141000	-125308000 Derived	Source 2014-01-01 – 2014-12-31: 35962000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -134719000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -162141000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -118100000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 7208000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	22853000	125651000 Derived	-102798000	38602000 Derived	-141400000	-86356000 Derived	Source 2015-01-01 – 2015-12-31: 22853000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -102798000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -141400000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -85115000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 1241000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	18482000	81525000 Derived	-63043000	38513000 Derived	-101556000	-66423000 Derived	Source 2016-01-01 – 2016-12-31: 18482000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -63043000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -101556000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -64500000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 1923000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 18.5M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Revenue	37970000	Revenue: 37970000 Open source
20112011-12-31	Revenue	38966000	Revenue: 38966000 Open source
20122012-12-31	Revenue	44108000	Revenue: 44108000 Open source
20132013-12-31	Revenue	39750000	Revenue: 39750000 Open source
20142014-12-31	Revenue	35962000	Revenue: 35962000 Open source
20152015-12-31	Revenue	22853000	Revenue: 22853000 Open source
20162016-12-31	Revenue	18482000	Revenue: 18482000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-19.1% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Year over year	No prior comparable period	Revenue: 37970000 Open source
20112011-12-31	Year over year	2.6%	Revenue: 38966000 Open source Revenue: 37970000 Open source
20122012-12-31	Year over year	13.2%	Revenue: 44108000 Open source Revenue: 38966000 Open source
20132013-12-31	Year over year	-9.9%	Revenue: 39750000 Open source Revenue: 44108000 Open source
20142014-12-31	Year over year	-9.5%	Revenue: 35962000 Open source Revenue: 39750000 Open source
20152015-12-31	Year over year	-36.5%	Revenue: 22853000 Open source Revenue: 35962000 Open source
20162016-12-31	Year over year	-19.1%	Revenue: 18482000 Open source Revenue: 22853000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -341.1% 2016

Net margin -549.5% 2016

Free cash flow margin -359.4% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20102010-12-31	Operating margin	-36%	Operating Income: -13679000 Open source Revenue: 37970000 Open source
20112011-12-31	Operating margin	-129.6%	Operating Income: -50493000 Open source Revenue: 38966000 Open source
20122012-12-31	Operating margin	-192.9%	Operating Income: -85103000 Open source Revenue: 44108000 Open source
20132013-12-31	Operating margin	-241.9%	Operating Income: -96140000 Open source Revenue: 39750000 Open source
20142014-12-31	Operating margin	-374.6%	Operating Income: -134719000 Open source Revenue: 35962000 Open source
20152015-12-31	Operating margin	-449.8%	Operating Income: -102798000 Open source Revenue: 22853000 Open source
20162016-12-31	Operating margin	-341.1%	Operating Income: -63043000 Open source Revenue: 18482000 Open source
20102010-12-31	Net margin	-42.9%	Net Income: -16280000 Open source Revenue: 37970000 Open source
20112011-12-31	Net margin	-138.3%	Net Income: -53901000 Open source Revenue: 38966000 Open source
20122012-12-31	Net margin	-188.5%	Net Income: -83132000 Open source Revenue: 44108000 Open source
20132013-12-31	Net margin	-292.8%	Net Income: -116389000 Open source Revenue: 39750000 Open source
20142014-12-31	Net margin	-450.9%	Net Income: -162141000 Open source Revenue: 35962000 Open source
20152015-12-31	Net margin	-618.7%	Net Income: -141400000 Open source Revenue: 22853000 Open source
20162016-12-31	Net margin	-549.5%	Net Income: -101556000 Open source Revenue: 18482000 Open source
20102010-12-31	Free cash flow margin	-28.5%	Revenue: 37970000 Open source Operating Cash Flow: -8309000 Open source Capital Expenditure: 2505000 Open source
20112011-12-31	Free cash flow margin	-129.4%	Revenue: 38966000 Open source Operating Cash Flow: -34905000 Open source Capital Expenditure: 15502000 Open source
20122012-12-31	Free cash flow margin	-181.7%	Revenue: 44108000 Open source Operating Cash Flow: -67571000 Open source Capital Expenditure: 12554000 Open source
20132013-12-31	Free cash flow margin	-213.9%	Revenue: 39750000 Open source Operating Cash Flow: -74790000 Open source Capital Expenditure: 10217000 Open source
20142014-12-31	Free cash flow margin	-348.4%	Revenue: 35962000 Open source Operating Cash Flow: -118100000 Open source Capital Expenditure: 7208000 Open source
20152015-12-31	Free cash flow margin	-377.9%	Revenue: 22853000 Open source Operating Cash Flow: -85115000 Open source Capital Expenditure: 1241000 Open source
20162016-12-31	Free cash flow margin	-359.4%	Revenue: 18482000 Open source Operating Cash Flow: -64500000 Open source Capital Expenditure: 1923000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -64.5M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Operating cash flow	-8309000	Operating Cash Flow: -8309000 Open source
20112011-12-31	Operating cash flow	-34905000	Operating Cash Flow: -34905000 Open source
20122012-12-31	Operating cash flow	-67571000	Operating Cash Flow: -67571000 Open source
20132013-12-31	Operating cash flow	-74790000	Operating Cash Flow: -74790000 Open source
20142014-12-31	Operating cash flow	-118100000	Operating Cash Flow: -118100000 Open source
20152015-12-31	Operating cash flow	-85115000	Operating Cash Flow: -85115000 Open source
20162016-12-31	Operating cash flow	-64500000	Operating Cash Flow: -64500000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -66.4M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20102010-12-31	Free cash flow	-10814000	Operating Cash Flow: -8309000 Open source Capital Expenditure: 2505000 Open source
20112011-12-31	Free cash flow	-50407000	Operating Cash Flow: -34905000 Open source Capital Expenditure: 15502000 Open source
20122012-12-31	Free cash flow	-80125000	Operating Cash Flow: -67571000 Open source Capital Expenditure: 12554000 Open source
20132013-12-31	Free cash flow	-85007000	Operating Cash Flow: -74790000 Open source Capital Expenditure: 10217000 Open source
20142014-12-31	Free cash flow	-125308000	Operating Cash Flow: -118100000 Open source Capital Expenditure: 7208000 Open source
20152015-12-31	Free cash flow	-86356000	Operating Cash Flow: -85115000 Open source Capital Expenditure: 1241000 Open source
20162016-12-31	Free cash flow	-66423000	Operating Cash Flow: -64500000 Open source Capital Expenditure: 1923000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

141.7% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Liabilities / assets	Not reported	No source recorded
20112011-12-31	Liabilities / assets	15.7%	Total Liabilities: 44666000 Open source Total Assets: 285224000 Open source
20122012-12-31	Liabilities / assets	15.5%	Total Liabilities: 33713000 Open source Total Assets: 217024000 Open source
20132013-12-31	Liabilities / assets	46.3%	Total Liabilities: 119757000 Open source Total Assets: 258705000 Open source
20142014-12-31	Liabilities / assets	72.4%	Total Liabilities: 226213000 Open source Total Assets: 312589000 Open source
20152015-12-31	Liabilities / assets	125.5%	Total Liabilities: 228447000 Open source Total Assets: 181972000 Open source
20162016-12-31	Liabilities / assets	141.7%	Total Liabilities: 192302000 Open source Total Assets: 135709000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.18× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2010-12-31	Current assets / current liabilities	Not reported	No source recorded
20112011-12-31	Current assets / current liabilities	8.86×	Current Assets: 258893000 Open source Current Liabilities: 29212000 Open source
20122012-12-31	Current assets / current liabilities	6.63×	Current Assets: 165279000 Open source Current Liabilities: 24938000 Open source
20132013-12-31	Current assets / current liabilities	7.58×	Current Assets: 191817000 Open source Current Liabilities: 25294000 Open source
20142014-12-31	Current assets / current liabilities	9.97×	Current Assets: 233927000 Open source Current Liabilities: 23454000 Open source
20152015-12-31	Current assets / current liabilities	4.7×	Current Assets: 118944000 Open source Current Liabilities: 25330000 Open source
20162016-12-31	Current assets / current liabilities	4.18×	Current Assets: 67999000 Open source Current Liabilities: 16287000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2010 2010-01-01 – 2010-12-31	−USD 16.28 million Exact value Exact value: -16280000 USD 2010-01-01 – 2010-12-31: -16280000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLAZYME INC · 2010-12-31 SOLAZYME INC (edgar:1311230) Net Income: -16280000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16280000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312513105081/szym-20121231.xml#158647 Filing: 000119312513105081 The citation records this snapshot. The page link may show a newer release later.	−USD 8.31 million Exact value Exact value: -8309000 USD 2010-01-01 – 2010-12-31: -8309000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLAZYME INC · 2010-12-31 SOLAZYME INC (edgar:1311230) Operating Cash Flow: -8309000 USD Concept: fundies:OperatingCashFlow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3AOperatingCashFlow&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8309000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312513105081/szym-20121231.xml#148433 Filing: 000119312513105081 The citation records this snapshot. The page link may show a newer release later.	USD 2.51 million Exact value Exact value: 2505000 USD 2010-01-01 – 2010-12-31: 2505000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLAZYME INC · 2010-12-31 SOLAZYME INC (edgar:1311230) Capital Expenditure: 2505000 USD Concept: fundies:CapitalExpenditure Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ACapitalExpenditure&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2505000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312513105081/szym-20121231.xml#149961 Filing: 000119312513105081 The citation records this snapshot. The page link may show a newer release later.	−USD 10.81 million Calculation and evidence -8309000 − 2505000 USD Exact free cash flow: -10814000 USD 2010-01-01 – 2010-12-31: -8309000 USD · Inspect Operating Cash Flow · Source 2010-01-01 – 2010-12-31: 2505000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLAZYME INC · 2010-12-31 SOLAZYME INC (edgar:1311230) Free cash flow: -10814000 USD Concept: free-cash-flow Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8309000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312513105081/szym-20121231.xml#148433 Filing: 000119312513105081 Input fundies:CapitalExpenditure: 2505000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312513105081/szym-20121231.xml#149961 Filing: 000119312513105081 The citation records this snapshot. The page link may show a newer release later.
2011 2011-01-01 – 2011-12-31	−USD 53.9 million Exact value Exact value: -53901000 USD 2011-01-01 – 2011-12-31: -53901000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLAZYME INC · 2011-12-31 SOLAZYME INC (edgar:1311230) Net Income: -53901000 USD Concept: fundies:NetIncome Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ANetIncome&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:NetIncome: -53901000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312514098366/szym-20131231.xml#176399 Filing: 000119312514098366 The citation records this snapshot. The page link may show a newer release later.	−USD 34.91 million Exact value Exact value: -34905000 USD 2011-01-01 – 2011-12-31: -34905000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLAZYME INC · 2011-12-31 SOLAZYME INC (edgar:1311230) Operating Cash Flow: -34905000 USD Concept: fundies:OperatingCashFlow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3AOperatingCashFlow&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -34905000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312514098366/szym-20131231.xml#164184 Filing: 000119312514098366 The citation records this snapshot. The page link may show a newer release later.	USD 15.5 million Exact value Exact value: 15502000 USD 2011-01-01 – 2011-12-31: 15502000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLAZYME INC · 2011-12-31 SOLAZYME INC (edgar:1311230) Capital Expenditure: 15502000 USD Concept: fundies:CapitalExpenditure Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ACapitalExpenditure&period=2011-12-31&surface=latest&period_type=duration&start=2011-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 15502000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312514098366/szym-20131231.xml#166916 Filing: 000119312514098366 The citation records this snapshot. The page link may show a newer release later.	−USD 50.41 million Calculation and evidence -34905000 − 15502000 USD Exact free cash flow: -50407000 USD 2011-01-01 – 2011-12-31: -34905000 USD · Inspect Operating Cash Flow · Source 2011-01-01 – 2011-12-31: 15502000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLAZYME INC · 2011-12-31 SOLAZYME INC (edgar:1311230) Free cash flow: -50407000 USD Concept: free-cash-flow Period: 2011-01-01 to 2011-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -34905000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312514098366/szym-20131231.xml#164184 Filing: 000119312514098366 Input fundies:CapitalExpenditure: 15502000 USD (2011-01-01 to 2011-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000119312514098366/szym-20131231.xml#166916 Filing: 000119312514098366 The citation records this snapshot. The page link may show a newer release later.
2012 2012-01-01 – 2012-12-31	−USD 83.13 million Exact value Exact value: -83132000 USD 2012-01-01 – 2012-12-31: -83132000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLAZYME INC · 2012-12-31 SOLAZYME INC (edgar:1311230) Net Income: -83132000 USD Concept: fundies:NetIncome Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ANetIncome&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:NetIncome: -83132000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000155566715000031/szym-20141231.xml#468298 Filing: 000155566715000031 The citation records this snapshot. The page link may show a newer release later.	−USD 67.57 million Exact value Exact value: -67571000 USD 2012-01-01 – 2012-12-31: -67571000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLAZYME INC · 2012-12-31 SOLAZYME INC (edgar:1311230) Operating Cash Flow: -67571000 USD Concept: fundies:OperatingCashFlow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3AOperatingCashFlow&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -67571000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000155566715000031/szym-20141231.xml#467661 Filing: 000155566715000031 The citation records this snapshot. The page link may show a newer release later.	USD 12.55 million Exact value Exact value: 12554000 USD 2012-01-01 – 2012-12-31: 12554000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLAZYME INC · 2012-12-31 SOLAZYME INC (edgar:1311230) Capital Expenditure: 12554000 USD Concept: fundies:CapitalExpenditure Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ACapitalExpenditure&period=2012-12-31&surface=latest&period_type=duration&start=2012-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12554000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000155566715000031/szym-20141231.xml#493249 Filing: 000155566715000031 The citation records this snapshot. The page link may show a newer release later.	−USD 80.13 million Calculation and evidence -67571000 − 12554000 USD Exact free cash flow: -80125000 USD 2012-01-01 – 2012-12-31: -67571000 USD · Inspect Operating Cash Flow · Source 2012-01-01 – 2012-12-31: 12554000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLAZYME INC · 2012-12-31 SOLAZYME INC (edgar:1311230) Free cash flow: -80125000 USD Concept: free-cash-flow Period: 2012-01-01 to 2012-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -67571000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000155566715000031/szym-20141231.xml#467661 Filing: 000155566715000031 Input fundies:CapitalExpenditure: 12554000 USD (2012-01-01 to 2012-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000155566715000031/szym-20141231.xml#493249 Filing: 000155566715000031 The citation records this snapshot. The page link may show a newer release later.
2013 2013-01-01 – 2013-12-31	−USD 116.39 million Exact value Exact value: -116389000 USD 2013-01-01 – 2013-12-31: -116389000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLAZYME INC · 2013-12-31 SOLAZYME INC (edgar:1311230) Net Income: -116389000 USD Concept: fundies:NetIncome Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ANetIncome&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:NetIncome: -116389000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123016000013/szym-20151231.xml#378896 Filing: 000131123016000013 The citation records this snapshot. The page link may show a newer release later.	−USD 74.79 million Exact value Exact value: -74790000 USD 2013-01-01 – 2013-12-31: -74790000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLAZYME INC · 2013-12-31 SOLAZYME INC (edgar:1311230) Operating Cash Flow: -74790000 USD Concept: fundies:OperatingCashFlow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3AOperatingCashFlow&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -74790000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123016000013/szym-20151231.xml#378259 Filing: 000131123016000013 The citation records this snapshot. The page link may show a newer release later.	USD 10.22 million Exact value Exact value: 10217000 USD 2013-01-01 – 2013-12-31: 10217000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLAZYME INC · 2013-12-31 SOLAZYME INC (edgar:1311230) Capital Expenditure: 10217000 USD Concept: fundies:CapitalExpenditure Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ACapitalExpenditure&period=2013-12-31&surface=latest&period_type=duration&start=2013-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10217000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123016000013/szym-20151231.xml#402830 Filing: 000131123016000013 The citation records this snapshot. The page link may show a newer release later.	−USD 85.01 million Calculation and evidence -74790000 − 10217000 USD Exact free cash flow: -85007000 USD 2013-01-01 – 2013-12-31: -74790000 USD · Inspect Operating Cash Flow · Source 2013-01-01 – 2013-12-31: 10217000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLAZYME INC · 2013-12-31 SOLAZYME INC (edgar:1311230) Free cash flow: -85007000 USD Concept: free-cash-flow Period: 2013-01-01 to 2013-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -74790000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123016000013/szym-20151231.xml#378259 Filing: 000131123016000013 Input fundies:CapitalExpenditure: 10217000 USD (2013-01-01 to 2013-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123016000013/szym-20151231.xml#402830 Filing: 000131123016000013 The citation records this snapshot. The page link may show a newer release later.
2014 2014-01-01 – 2014-12-31	−USD 162.14 million Exact value Exact value: -162141000 USD 2014-01-01 – 2014-12-31: -162141000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLAZYME INC · 2014-12-31 SOLAZYME INC (edgar:1311230) Net Income: -162141000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -162141000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#398545 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	−USD 118.1 million Exact value Exact value: -118100000 USD 2014-01-01 – 2014-12-31: -118100000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLAZYME INC · 2014-12-31 SOLAZYME INC (edgar:1311230) Operating Cash Flow: -118100000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -118100000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#396572 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	USD 7.21 million Exact value Exact value: 7208000 USD 2014-01-01 – 2014-12-31: 7208000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLAZYME INC · 2014-12-31 SOLAZYME INC (edgar:1311230) Capital Expenditure: 7208000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 7208000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423316 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	−USD 125.31 million Calculation and evidence -118100000 − 7208000 USD Exact free cash flow: -125308000 USD 2014-01-01 – 2014-12-31: -118100000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 7208000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLAZYME INC · 2014-12-31 SOLAZYME INC (edgar:1311230) Free cash flow: -125308000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -118100000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#396572 Filing: 000131123017000008 Input fundies:CapitalExpenditure: 7208000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423316 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 141.4 million Exact value Exact value: -141400000 USD 2015-01-01 – 2015-12-31: -141400000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLAZYME INC · 2015-12-31 SOLAZYME INC (edgar:1311230) Net Income: -141400000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -141400000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#399695 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	−USD 85.12 million Exact value Exact value: -85115000 USD 2015-01-01 – 2015-12-31: -85115000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLAZYME INC · 2015-12-31 SOLAZYME INC (edgar:1311230) Operating Cash Flow: -85115000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -85115000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#396997 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	USD 1.24 million Exact value Exact value: 1241000 USD 2015-01-01 – 2015-12-31: 1241000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLAZYME INC · 2015-12-31 SOLAZYME INC (edgar:1311230) Capital Expenditure: 1241000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1241000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423526 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	−USD 86.36 million Calculation and evidence -85115000 − 1241000 USD Exact free cash flow: -86356000 USD 2015-01-01 – 2015-12-31: -85115000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 1241000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLAZYME INC · 2015-12-31 SOLAZYME INC (edgar:1311230) Free cash flow: -86356000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -85115000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#396997 Filing: 000131123017000008 Input fundies:CapitalExpenditure: 1241000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423526 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 101.56 million Exact value Exact value: -101556000 USD 2016-01-01 – 2016-12-31: -101556000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Net Income: -101556000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -101556000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#400690 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	−USD 64.5 million Exact value Exact value: -64500000 USD 2016-01-01 – 2016-12-31: -64500000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Operating Cash Flow: -64500000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -64500000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#397421 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	USD 1.92 million Exact value Exact value: 1923000 USD 2016-01-01 – 2016-12-31: 1923000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Capital Expenditure: 1923000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1923000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423736 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.	−USD 66.42 million Calculation and evidence -64500000 − 1923000 USD Exact free cash flow: -66423000 USD 2016-01-01 – 2016-12-31: -64500000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 1923000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SOLAZYME INC · 2016-12-31 SOLAZYME INC (edgar:1311230) Free cash flow: -66423000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T14:07:39Z Snapshot: 054495101d494372c20980625ac8156aff4334a58140738e8e1d05cca59ee14b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1311230?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -64500000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#397421 Filing: 000131123017000008 Input fundies:CapitalExpenditure: 1923000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1311230/000131123017000008/tvia-20161231.xml#423736 Filing: 000131123017000008 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

29 filings · 2,398 latest values · 2,398 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001311230, 1311230, SZYM, TVIA, edgar:1311230

Also known as SOLAZYME INC, TerraVia Holdings, Inc.

SOLAZYME INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2016 2016-01-01 – 2016-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation